Nortec Quimica Bupivacaine HCL Nortec Quimica Bupivacaine HCL

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Bupivacaine Hydrochloride

    Client Email Product

    Bupivacaine Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    27
    US DMFs Filed

    US DMFs Filed

    7
    CEP/COS Certifications

    CEP/COS Certifications

    6
    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    5
    Other Suppliers

    Other Suppliers

    20
    API REF. PRICE (USD / KG)
    845

    API Market Place

    21
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    79
    Europe

    Europe

    9
    Canada

    Canada

    18
    Australia

    Australia

    0

    South Africa

    South Africa

    4
    Uploaded Dossiers

    Uploaded Dossiers

    18
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    2
    EXCIPIENTS
    11
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    2

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    38
    REF STANDARD

    EDQM

    4

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;INJECTION - 0.25%
    • INJECTABLE;INJECTION - 0.25%;0.0091MG/ML
    • INJECTABLE;INJECTION - 0.5%
    • INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
    • INJECTABLE;INJECTION - 0.75%
    • INJECTABLE;INJECTION - 0.75%;0.0091MG/ML
    • INJECTABLE;INJECTION - 0.25%
    • INJECTABLE;INJECTION - 0.5%
    • INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
    • INJECTABLE;INJECTION - 0.75%
    • INJECTABLE;INJECTION - 0.75%;0.0091MG/ML
    • INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
    Full View ScreenFull Screen View
    Enforcement Report - Week of January 25, 2023
    Enforcement Report - Week of January 25, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf

    FDA
    25 Jan 2023
    Share Share
    Enforcement Report - Week of September 21, 2022
    Enforcement Report - Week of September 21, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-21-2022-99399.pdf

    FDA
    21 Sep 2022
    Share Share
    Enforcement Report - Week of August 24, 2022
    Enforcement Report - Week of August 24, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-24-2022-1661335123.pdf

    FDA
    24 Aug 2022
    Share Share
    Enforcement Report - Week of June 15, 2022
    Enforcement Report - Week of June 15, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-15-2022-1655268880.pdf

    FDA
    14 Jun 2022
    Share Share
    Innocoll Shows Positive Topline Results For XARACOLL implant in Phase 3 Study
    Innocoll Shows Positive Topline Results For XARACOLL implant in Phase 3 Study

    https://www.businesswire.com/news/home/20220302005437/en

    BUSINESSWIRE
    02 Mar 2022
    Share Share
    Enforcement Report - Week of August 18, 2021
    Enforcement Report - Week of August 18, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-18-2021-1629274448.pdf

    FDA
    18 Aug 2021
    Share Share
    Enforcement Report- Week of June 9, 2021
    Enforcement Report- Week of June 9, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-9-2021-1623238294.pdf

    FDA
    09 Jun 2021
    Share Share
    Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection
    Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection

    https://www.pharmacompass.com/pdf/news/hospira-issues-a-voluntary-nationwide-recall-for-one-lot-of-05-bupivacaine-hydrochloride-injection-1620284826.pdf

    FDA
    06 May 2021
    Share Share
    Enforcement Report - Week of December 30, 2020
    Enforcement Report - Week of December 30, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf

    FDA
    30 Dec 2020
    Share Share
    Enforcement Report - Week of November 18, 2020
    Enforcement Report - Week of November 18, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-18-2020-1605674129.pdf

    FDA
    18 Nov 2020
    Share Share
    Novel non-opioid postsurgical pain implant launched
    Novel non-opioid postsurgical pain implant launched

    https://www.europeanpharmaceuticalreview.com/news/131941/novel-non-opioid-postsurgical-pain-implant-xaracoll-launched/

    Hannah Balfour EUROPEANPHARMACEUTICALREVIEW
    30 Oct 2020
    Share Share
    Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI)
    Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI)

    https://www.prnewswire.com/news-releases/innocoll-announces-commercial-launch-of-xaracoll-bupivacaine-hci-implant-a-non-opioid-drug-device-treatment-option-for-acute-postsurgical-pain-relief-for-up-to-24-hours-following-open-inguinal-hernia-repair-in-adults-301163002.html

    PRNEWSWIRE
    29 Oct 2020
    Share Share
    Innocoll Holdings Announces FDA Acceptance ofnda for XARACOLL®
    Innocoll Holdings Announces FDA Acceptance ofnda for XARACOLL®

    https://www.prnewswire.com/news-releases/innocoll-holdings-limited-announces-fda-acceptance-of-new-drug-application-for-xaracoll-for-the-management-of-postsurgical-pain-after-open-inguinal-hernia-surgery-301030493.html

    PR NEWSWIRE
    27 Mar 2020
    Share Share
    Innocoll Holdings Resubmits New Drug Application to FDA for XARACOLL®
    Innocoll Holdings Resubmits New Drug Application to FDA for XARACOLL®

    https://www.prnewswire.com/news-releases/innocoll-holdings-limited-resubmits-new-drug-application-to-fda-for-xaracoll-for-the-management-of-postsurgical-pain-after-open-inguinal-hernia-surgery-301012890.html

    PR NEWSWIRE
    28 Feb 2020
    Share Share
    Innocoll Holdings Resubmits New Drug Application to FDA for XARACOLL®
    Innocoll Holdings Resubmits New Drug Application to FDA for XARACOLL®

    https://www.prnewswire.com/news-releases/innocoll-holdings-limited-resubmits-new-drug-application-to-fda-for-xaracoll-for-the-management-of-postsurgical-pain-after-open-inguinal-hernia-surgery-301012890.html

    PR NEWSWIRE
    28 Feb 2020
    Share Share
    Innocoll Holdings Resubmits NDA to FDA for XARACOLL®
    Innocoll Holdings Resubmits NDA to FDA for XARACOLL®

    https://www.prnewswire.com/news-releases/innocoll-holdings-limited-resubmits-new-drug-application-to-fda-for-xaracoll-for-the-management-of-postsurgical-pain-after-open-inguinal-hernia-surgery-301012890.html

    PR NEWSWIRE
    27 Feb 2020
    Share Share
    Huons Generic Bupivacaine Hydrochloride Receives Approval in US
    Huons Generic Bupivacaine Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212822

    FDA
    30 Dec 2019
    Share Share
    Enforcement Report - Week of December 18, 2019
    Enforcement Report - Week of December 18, 2019

    FDA
    18 Dec 2019
    Share Share
    Big Pharma joins £200M UK Biobank sequencing project
    Big Pharma joins £200M UK Biobank sequencing project

    https://endpts.com/big-pharma-joins-200m-uk-biobank-sequencing-project-monopar-sets-terms-for-40m-ipo/

    Kathy Wong ENDPOINTS NEWS
    12 Sep 2019
    Share Share
    Enforcement Report - Week of April 24, 2019
    Enforcement Report - Week of April 24, 2019

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-24-2019-1556080066.pdf

    FDA
    24 Apr 2019
    Share Share
    B Braun Medical`s Generic Bupivacaine Hydrochloride Receives Approval in US
    B Braun Medical`s Generic Bupivacaine Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209087

    FDA
    05 Apr 2019
    Share Share
    Novocol's Generic Bupivacaine Hydrochloride Receives Approval in US
    Novocol's Generic Bupivacaine Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211096

    FDA
    23 Feb 2019
    Share Share
    Enforcement Report - Week of February 28, 2018
    Enforcement Report - Week of February 28, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

    FDA
    28 Feb 2018
    Share Share
    Enforcement Report - Week of July 12, 2017
    Enforcement Report - Week of July 12, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2017-1499837241.pdf

    FDA
    12 Jul 2017
    Share Share
    Innocoll Announces Top-Line Data From Phase 3 Trials
    Innocoll Announces Top-Line Data From Phase 3 Trials

    https://globenewswire.com/news-release/2016/11/03/886646/0/en/Innocoll-Announces-Top-Line-Data-From-Phase-3-Trials-With-COGENZIA-and-NDA-Submission-for-XARACOLL.html

    GLOBENEWSWIRE
    03 Nov 2016
    Share Share
    Hospira Healthcare Corporation Issues Voluntary Nationwide Recall Of Marcaine 0.50% Due To Defect Possible That Could Compromise The Sealing Plugs
    Hospira Healthcare Corporation Issues Voluntary Nationwide Recall Of Marcaine 0.50% Due To Defect Possible That Could Compromise The Sealing Plugs

    https://www.pharmacompass.com/pdf/news/hospira-healthcare-corporation-issues-voluntary-nationwide-recall-of-marcaine-050-due-to-defect-possible-that-could-compromise-the-sealing-plugs-1474463515.pdf

    Healthcanada
    20 Sep 2016
    Share Share
    Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine
    Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine

    https://www.pharmacompass.com/pdf/news/hospira-issues-a-voluntary-nationwide-recall-for-one-lot-of-025-bupivacaine-1470727081.pdf

    FDA
    05 Aug 2016
    Share Share
    Claris Life Gets USFDA Nod For Gneric Anesthetic Injection Bupivacaine
    Claris Life Gets USFDA Nod For Gneric Anesthetic Injection Bupivacaine

    https://www.pharmacompass.com/pdf/news/claris-life-gets-usfda-nod-for-gneric-anesthetic-injection-bupivacaine-1469863262.pdf

    FDA
    25 Jul 2016
    Share Share
    Aurobindo Pharma gets USFDA nod for anesthetic injection
    Aurobindo Pharma gets USFDA nod for anesthetic injection

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-anesthetic-injection/articleshow/52291199.cms

    ECONOMIC TIMES
    16 May 2016
    Share Share
    Aurobindo's Generic Bupivacaine HCl approved in US as local anesthetic agent
    Aurobindo's Generic Bupivacaine HCl approved in US as local anesthetic agent

    https://www.pharmacompass.com/pdf/news/aurobindos-generic-bupivacaine-hcl-approved-in-us-as-local-anesthetic-agent-1463569802.pdf

    FDA
    13 May 2016
    Share Share
    PharMEDium Issues Voluntary Nationwide Recall Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF
    PharMEDium Issues Voluntary Nationwide Recall Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF

    http://www.fda.gov/Safety/Recalls/ucm499760.htm

    FDA
    05 May 2016
    Share Share
    DURECT Announces POSIMIR® Program Update
    DURECT Announces POSIMIR® Program Update

    http://www.prnewswire.com/news-releases/durect-announces-posimir-program-update-300248074.html

    PR NEWSWIRE
    10 Apr 2016
    Share Share
    Apotheca Supply, Inc receives warning letter due to cGMP deviations
    Apotheca Supply, Inc receives warning letter due to cGMP deviations

    https://www.pharmacompass.com/pdf/news/apotheca-supply-inc-receives-warning-letter-due-to-cgmp-deviations-1484160849.pdf

    FDA
    07 Apr 2016
    Share Share
    US FDA Enforcement report - 16/Mar/2016
    US FDA Enforcement report - 16/Mar/2016

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-16mar2016-1458126358.pdf

    FDA
    16 Mar 2016
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Drug shortages become issue in Teva and Mylan hook-up
    Drug shortages become issue in Teva and Mylan hook-up

    http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30

    Eric Palmer FIERCE PHARMA MANUFACTURING
    30 Apr 2015
    Share Share
    Another Hospira problem, Bupivacaine HCl injection recall.
    Another Hospira problem, Bupivacaine HCl injection recall.

    http://www.fda.gov/Safety/Recalls/ucm444356.htm

    Press Release FDA
    25 Apr 2015
    Share Share
    FDA Drug Shortages: Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection
    FDA Drug Shortages: Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection

    http://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine+Hydrochloride+%28Marcaine%2C+Sensorcaine%29+Injection&source=govdelivery&st=c&tab=tabs-4&utm_medium=email&utm_source=govdelivery

    FDA
    25 Mar 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search